Israel: An upgraded facility and a new site for advanced cell culture media production
Video: Guided tour of Sartorius site in Beit Haemek, Israel - Originally broadcast live on Monday, June 28, 2021.
Sartorius is expanding its production capabilities in Israel with a new site for advanced cell culture media production and an upgrade of the the existing facility. The new site will serve as the main production site for liquid media and buffers.
This article is posted on Sartorius Blog.
Sartorius opened a new site in Beit Haemek, Israel, which focuses on specialty and customized cell culture media, particularly for the advanced therapies market. With the expansion, the plant will serve as the main production site for liquid media and buffers and will be able to produce nearly five times its current output. The new facility has been designed to meet the highest manufacturing and regulatory standards. It covers 11,800 square feet and includes Grades B and C cleanrooms as well as on-site equipment. The existing facility will be upgraded as well to prepare for future demand.
The team in Israel has a long track record and experience in the advanced therapies market – from development to the production and sale of cell culture solutions. With the new state‑of‑the‑art facility in Beit Haemek, we can build on this expertise and leverage the existing infrastructure to further grow this business.
René Fáber, Head of the Bioprocess Solutions Division of Sartorius, Member of the Executive Board
Background: In December 2019, Sartorius acquired a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries. The integration of the cell culture media production business has been essential in Sartorius’ key initiative to further develop its business and expertise in the advanced therapies segment.
In 2021, Sartorius will invest more than 400 million euros in the expansion of manufacturing capacities around the world to meet the high demand from the growing biopharmaceuticals market. In line with these investments, Sartorius aims to expand its Beit Haemek site, and the company is now offering several positions in Israel among other job vacancies worldwide.
Sartorius expects continuous strong growth for the current fiscal year and beyond. To support this growth, and to ensure delivery reliability also going forward, we have started to accelerate and extend the expansion of our production capacities very significantly in all geographies, the Americas, Europe, and Asia. By 2025, Sartorius will more than double capacities for key product groups.
Products: Cell Culture Media and Buffers
Slovenia: An expanded production site for purification and analytical products
Havant: A state-of-the-art facility for downstream processing equipment
Beijing: A new Customer Interaction Center for the Chinese Market
Sartorius to open new Customer Interaction Center in North America